TrialThe New England journal of medicine2022
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Matthew R Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
496 papers cite itlatest 60 shown
this paperpooled ittrialcites it